Varonis Introduces DatAdvantage Cloud to Bring Data-Centric Security to Additional Mission-Critical Cloud Services
Varonis adds support for AWS, Box, GitHub, Google Drive, Jira, Okta, Salesforce, Slack, and Zoom…
Varonis adds support for AWS, Box, GitHub, Google Drive, Jira, Okta, Salesforce, Slack, and Zoom…
Sandoz to invest €150 million in new antibiotics manufacturing technology in Europe over next three…
The information contained within this announcement is deemed by the Company to constitute inside information…
CoVepiT is a SARS-CoV-2 vaccine activating T cell defences through CD8 T cell multi-epitopes. CoVepiT…
ALLSCHWIL, Switzerland, May 18, 2021 (GLOBE NEWSWIRE) — Polyphor AG (SIX: POLN) a research driven…
eureKARE launches with $60 million to build and finance next generation biotech companies in Europe…
Monthly information regarding the total number of voting rights and total number of shares of…
PALATINE, Ill., May 17, 2021 (GLOBE NEWSWIRE) — Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative…
REDUCE-IT® patients experienced substantial cardiovascular (CV) risk reduction with icosapent ethyl regardless of the presence…
– Reported 50% response rate in visual sensitivity among patients in highest dose groups in…
– ANX005 Huntington’s Disease Phase 2 trial fully enrolled with data anticipated 2H 2021 –…
COPENHAGEN, Denmark, May 17, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical…
SAN DIEGO, May 17, 2021 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced…
REDWOOD CITY, Calif., May 17, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading enzyme…
BURLINGAME, Calif., May 17, 2021 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq:…
Kathleen Lynch has joined as Head of Global Government Affairs and Communications and Michele Farmer has…
– Recent New Drug Application Resubmission for XIPERETM (triamcinolone acetonide suprachoroidal injectable suspension) – –…
REDWOOD CITY, Calif., May 17, 2021 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage…
KIN-2787 is the company’s RAF inhibitor candidate for patients with mutant BRAF-driven solid tumors Planned…
FLT190 Phase 1/2 dose-finding study in Fabry disease on track to dose additional patients; Company to…